Permanent neonatal diabetes mellitus-3 (PNDM3) is characterized by the onset of mild to severe hyperglycemia within the first months of life, and requires lifelong therapy . Some patients also have neurologic features, including developmental delay and epilepsy. The triad of developmental delay, epilepsy, and neonatal diabetes is known as DEND. [From OMIM]